Jump Financial’s Celularity CELU Stock Holding History

Jump Financial’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,260	Closed	-$43K	–	1627
2022 Q2	$43K	Buy	+1,260	New	+$102K	﹤0.01%	1514

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LDFO

Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jump Financial's CELU Position: Q3 2022 in Review

Jump Financial sold out of Celularity (CELU) in Q3 2022, closing a stake of 1,260 shares — an estimated $43K sold.

Jump Financial first reported a position in CELU in Q2 2022 and held it in 1 quarter. The position peaked at $43K in Q2 2022. 72 funds tracked by Wall St. Rank hold CELU as of Q3 2022.

Jump Financial reported no remaining Celularity position as of Q3 2022 after selling out during the quarter.
Jump Financial sold 1,260 Celularity shares in Q3 2022, an estimated $43K.
Jump Financial first reported a position in Celularity in Q2 2022 and held it in 1 quarter.
Jump Financial's Celularity position peaked at $43K in Q2 2022.
72 funds tracked by Wall St. Rank held Celularity as of Q3 2022.

Based on Jump Financial's 13F filing for Q3 2022, filed 7 Nov 2022.